Answers are grounded in this paper and cite their sources.
This Viewpoint discusses a federal policy loophole that allows psychotropic cannabis products to be commercially marketed and sold across the US, even in states where recreational cannabis is not legal.
No takes yet. Share an insight, caveat, or question.
Harlow et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: